Related Experiment Videos

Translation initiation in cancer: a novel target for therapy

Funda Meric1, Kelly K Hunt

  • 1Department of Surgical Oncology, Box 444, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. fmeric@mdanderson.org

Insights

Cancer cells reprogram translation initiation for growth. Understanding these changes and targeting translation offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Translation initiation is a key regulatory point for protein synthesis, influencing cell growth and proliferation.
  • Aberrant translational control is a hallmark of cancer, impacting oncogenesis.
  • Changes in mRNA variants, translational machinery, and signaling pathways contribute to cancer development.

Purpose of the Study:

  • To review the fundamental principles of translational control.
  • To examine alterations in translational control specific to cancer.
  • To discuss therapeutic strategies targeting translation initiation in cancer.

Main Methods:

  • Literature review of basic principles of translational control.
  • Analysis of alterations in translational control in cancer.
  • Survey of current therapies targeting translation initiation.

Main Results:

  • Nutrient availability and mitogenic signals regulate translation initiation, linking it to cell cycle progression.
  • Cancer involves diverse alterations in translational control, including variant mRNA sequences and changes in translational machinery.
  • Signal transduction pathways activate translation, promoting synthesis of proteins crucial for cell growth and proliferation.

Conclusions:

  • Dysregulated translation initiation is integral to cancer biology.
  • Targeting translation initiation presents promising therapeutic avenues for cancer treatment.
  • Further research into translational control mechanisms can uncover novel anti-cancer strategies.

Related Concept Videos